Lambiase, A.; Sacchetti, M.; Mallone, F.; Tirassa, P.; Greco, A.; Angeloni, A.; Polimeni, A.
Evaluation of the Effectiveness of BNT162b2 Primary Vaccination and Booster Dose to SARS-CoV-2 in Eliciting Stable Mucosal Immunity. Biomedicines 2022, 10, 2430.
https://doi.org/10.3390/biomedicines10102430
AMA Style
Lambiase A, Sacchetti M, Mallone F, Tirassa P, Greco A, Angeloni A, Polimeni A.
Evaluation of the Effectiveness of BNT162b2 Primary Vaccination and Booster Dose to SARS-CoV-2 in Eliciting Stable Mucosal Immunity. Biomedicines. 2022; 10(10):2430.
https://doi.org/10.3390/biomedicines10102430
Chicago/Turabian Style
Lambiase, Alessandro, Marta Sacchetti, Fabiana Mallone, Paola Tirassa, Antonio Greco, Antonio Angeloni, and Antonella Polimeni.
2022. "Evaluation of the Effectiveness of BNT162b2 Primary Vaccination and Booster Dose to SARS-CoV-2 in Eliciting Stable Mucosal Immunity" Biomedicines 10, no. 10: 2430.
https://doi.org/10.3390/biomedicines10102430
APA Style
Lambiase, A., Sacchetti, M., Mallone, F., Tirassa, P., Greco, A., Angeloni, A., & Polimeni, A.
(2022). Evaluation of the Effectiveness of BNT162b2 Primary Vaccination and Booster Dose to SARS-CoV-2 in Eliciting Stable Mucosal Immunity. Biomedicines, 10(10), 2430.
https://doi.org/10.3390/biomedicines10102430